Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
ERCC2 validated as chemotherapy response biomarker in bladder cancer

ERCC2 validated as chemotherapy response biomarker in bladder cancer

Study provides valuable insight into biology of tumours in early stages of cancer

Study provides valuable insight into biology of tumours in early stages of cancer

Immunotherapy drugs given after chemotherapy may benefit ovarian cancer patients

Immunotherapy drugs given after chemotherapy may benefit ovarian cancer patients

Novel enzyme immunoassay helps diagnose HCV infection in one simple step

Novel enzyme immunoassay helps diagnose HCV infection in one simple step

Nivolumab drug benefits metastatic RCC patients who continued treatment beyond progression

Nivolumab drug benefits metastatic RCC patients who continued treatment beyond progression

Panel of microRNAs can predict patients at risk for developing HBV-driven liver cancer

Panel of microRNAs can predict patients at risk for developing HBV-driven liver cancer

New technique helps identify link between fatty acids and breast cancer in postmenopausal women

New technique helps identify link between fatty acids and breast cancer in postmenopausal women

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

Metformin along with chemotherapy/radiation improves outcomes in head and neck cancer patients

New research reveals advances that could change gynecologic cancer standard-of-care treatments

New research reveals advances that could change gynecologic cancer standard-of-care treatments

Clinical study finds two topical skin creams as effective noninvasive treatments for low-risk superficial BCC

Clinical study finds two topical skin creams as effective noninvasive treatments for low-risk superficial BCC

Nivolumab and ipilimumab combination could lead to effective treatment options for SCLC patients

Nivolumab and ipilimumab combination could lead to effective treatment options for SCLC patients

Researchers identify potential therapeutic target against oncogenic viral infection

Researchers identify potential therapeutic target against oncogenic viral infection

Researchers identify new genetic drivers of adrenal cancer

Researchers identify new genetic drivers of adrenal cancer

Vismodegib drug shows no addded benefit in advanced or symptomatic metastatic BCC patients

Vismodegib drug shows no addded benefit in advanced or symptomatic metastatic BCC patients

Scientists debate role of AAV in causing hepatocellular carcinoma

Scientists debate role of AAV in causing hepatocellular carcinoma

Researchers discover new potential treatment target for liver cancer

Researchers discover new potential treatment target for liver cancer

Ongoing treatment with nivolumab shows benefit in advanced kidney cancer patients

Ongoing treatment with nivolumab shows benefit in advanced kidney cancer patients

High levels of p62 protein in liver linked to cancer recurrence

High levels of p62 protein in liver linked to cancer recurrence

AstraZeneca, MedImmune to provide update on extensive oncology pipeline at ASCO 2016

AstraZeneca, MedImmune to provide update on extensive oncology pipeline at ASCO 2016

Study assesses utility of tumor cfDNA as predictor of therapeutic response to immunotherapy

Study assesses utility of tumor cfDNA as predictor of therapeutic response to immunotherapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.